We’re delighted to 📣 the appointment of🌟@ryanmbuch🌟as
our new Hepatology Consultant @UHSFT & Associate Professor @unisouthampton 🎉🎊🎈
He brings skills hugely complementary to our services. Future looks bright for our patients @Marktheliverdoc@helpatologist@janishapatel2
@AmranMR_@RoyalSurrey@NIHRresearch@UKRI_News@adilray Delighted & grateful to our partners & NIHR/UKRI in recent further funding & support, national evaluation program of ongoing ‘COBHAM study’ understanding power of digital media & influencers in COVID19 testing & vaccination uptake in UK ethnic minority groups #Covid19
Excited to be kicking off the evaluation phase of the COBHAM study (COVID-19 & Ethnicity @RoyalSurrey) funded by @NIHRresearch & @UKRI_News.
Check out our interventions on https://t.co/OeWdPSo8hG, with films featuring the community, @adilray, Art Malik and Sir Trevor McDonald!
Excellent, troubling new analyses led by @Ladyroho@bengoldacre et al. Nice linked editorial by @AliRacaniere https://t.co/ITigMJ8eqY. In pandemic wave 2, South Asians had even higher rates of infection, admission, mortality. Structural inequalities. https://t.co/PX4EaxQEsm
Post-COVID syndrome after hospitalization-our latest work led by @dayoubkhani @Vnafilyan@ben_humberstone@kamleshkhunti. 47,780 individuals with matched controls. Mean age 65 years, 55% male. 140 days mean follow-up. (1/4) https://t.co/G1kEnYTRhx
SAGE papers on #CovidVaccine hesitancy in ethnic populations published
Thanks to @JuliaHCox QResearch data show
In previous programmes (flu etc) minority populations 10-20% less likely to be vaccinated
⬆️ uptake in Bangladeshi populations
https://t.co/MWhEgkiaVB
Thread1/3
Our @NIHRresearch supported work demonstrates engagement of ethnic minority communities is critical in building trust and improving health outcomes.
A model which can be upscaled to the national #COVID19 vaccination programme.
https://t.co/vVkq0pR6tA
We can build on our developing links with the community. Learning invaluable lessons from our community and faith settings shows we can significantly improve uptake of hepatitis testing in high risk groups which we can easily translate to COVID-19 testing and vaccination uptake.